-

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Bally’s Corp. (NYSE: BALY) Shareholder Buyout and Encourages Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of Bally’s Corporation (“Bally’s”) (NYSE: BALY) shareholders on behalf of the company’s investors.

On July 25, 2024, Bally’s announced that it had agreed to be acquired by its largest shareholder, Standard General L.P., at a price of $18.25 per share. Following the closing of the proposed transaction, Bally’s shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

The investigation thus far has revealed that the process leading up to the announcement of the buyout appears to have significant conflicts of interest, thus making the sales process as well as the price-per-share appear unfair to the company’s shareholders. Notably, prior to the announcement of the proposed buyout, at least two stock analysts were maintaining a price target for BALY shares in excess of $30.00 per share.

Bally’s shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights at (484) 229 – 0750, or by clicking on the following link (or if necessary, by copying and pasting the link into your browser):

https://kaskelalaw.com/case/ballys-corp-buyout/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:BALY

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation into Fairness of $9.50 Per Share Global Business Travel Group (GBTG) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the recently announced buyout of Global Business Travel Group, Inc. (NYSE: GBTG) (“GBTG”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their GBTG shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, GBTG announced that it had agreed to go privat...

Kaskela Law LLC Announces Shareholder Investigation of Playtika Holding Corp. and Encourages Investors with Losses to Contact the Firm – PLTK

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating Playtika Holding Corp. (NASDAQ: PLTK) (“Playtika”) on behalf of the company’s investors. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/playtika-holding/ Since July 2025, shares of Playtika’s common stock have declined in value from a trading price of over $4.50 per share to a current price of less than $3.50 per share, a decline of over 22%...

Kaskela Law LLC Announces Investigation into Fairness of $16.50 Per Share Select Medical Holdings (SEM) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating the fairness of the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced th...
Back to Newsroom